Katy Marshall

DocwireNews

A new study led by Drs. Mao-Lin Yan and Yao-Dong Wang proposes that salvage hepatectomy may not provide substantial benefits to patients with unresectable hepatocellular carcinoma (uHCC) who demonstrate clinical complete response (cCR).
The study was <a href="https://www.dovepress.com/clinical-complete-response-after-conversion-therapy-for-unresectable-h-peer-reviewed-fulltext-article-JHC" target="_blank" rel="noopener">published in the Journal of Hepatocellular Carcinoma</a>.
Researchers analyzed data from 74 patients with uHCC and cCR who received conversion therapy at 7 major cancer centers in China between October 2018 and December 2021. They performed 1-to-1 propensity score matching (PSM) and compared disease-free survival (DFS) and progression-free survival (PFS) between the surgical group and the nonsurgical group.
Of the 74 patients, 45 underwent salvage hepatectomy and 29 were provided nonsurgical treatment.
In the surgical cohort, the 1-, 2-, and 3-year PFS rates were 77.8%, 61.5%, and 61.5%, respectively, and 81.2%, 60.9%, and 60.9%, respectively, in the nonsurgical cohort. For overall survival (OS), the 1-, 2-, and 3-year rates were 92.9%, 92.9%, and 69.7%, respectively, in the surgical group and 100.0%, 70.0%, and 70.0%, respectively, in the nonsurgical group.
Before PSM, investigators reported no significant differences in DFS (hazard ratio [HR], 0.715; 95% CI, 0.250-2.043; P=.531) and OS (HR, 0.980; 95% CI, 0.177-5.418; P=.982) when comparing the surgical and nonsurgical groups. Following PSM, researchers found no discrepancies in DFS and OS between the groups.
Patients who received nonsurgical treatment demonstrated a similar long-term survival rate to those with cCR who underwent salvage hepatectomy.
The investigators concluded that cCR following conversion therapy resulted in a positive prognosis for patients with uHCC and that nonsurgical treatment provides comparable benefits to salvage hepatectomy.
“It tends to show that salvage hepatectomy may not be essential for uHCC patients with cCR, especially in patients with a high risk of surgical complications,” the researchers wrote. “Prospective trials with long-term follow-up periods are warranted to evaluate this promising treatment modality.”

Rob Dillard

Continuation of JAK Inhibitor Therapy Prevents Relapse in Patients With Ulcerative Colitis

DDW 2024

Many Black and Hispanic Patients With Inflammatory Bowel Disease Suffer in Silence With Post-Traumatic Stress

"Top-down" Therapy is Optimal for Patients With Newly Diagnosed Crohn Disease

Latest News

Does Salvage Hepatectomy Benefit Patients With Unresectable HCC, cCR After Conversion Therapy?

Unresectable HCC

Researchers compared the data of patients who underwent salvage hepatectomy and those who received nonsurgical treatment. 

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Diabetes

Neurology

Rheumatology

Gastroenterology

Pulmonology

Ophthalmology

Infectious Diseases

— HIV

Health and Wellness

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Fellow on Call

Healthcare Unfiltered

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Career Center

Expert Interviews

Subscribe